Literature DB >> 14578101

Monocyte enrichment from leukapharesis products for the generation of DCs by plastic adherence, or by positive or negative selection.

T Felzmann1, V Witt, D Wimmer, G Ressmann, D Wagner, P Paul, K Hüttner, G Fritsch.   

Abstract

BACKGROUND: DCs for use in immunotherapy are frequently generated from peripheral blood monocytes. However, there are different approaches to monocyte enrichment.
METHOD: Plastic adherence is a widely used method for the enrichment of monocytes collected in a leukapheresis procedure. Alternatively,monocytes may be enriched by positive selection using magnetic beads coupled to CD14 Abs, or by cell depletion using beads coupled to Abs against CD2 and CD19 to remove non-monocytes.
RESULTS: Positive selection resulted in the highest purity of immature DCs (97 +/- 1%), but in a low yield (8 +/- 3%). In contrast, depletion of non-monocytes gave a good yield (21 +/- 6%), but insufficient purity (42 +/- 10%). Conventional adherence procedures resulted in a good yield (25 +/- 5%) and reasonable purity (72 +/- 4%). All three monocyte enrichment procedures resulted in DCs that underwent maturation upon exposure to a combination of lipopolysaccharide and IFN-gamma. These DCs had a typical immune phenotype, they released similar amounts of IL-12, and had the capacity to support MLR.
CONCLUSION: Our data provide a basis to choose a monocyte enrichment procedure that favors high purity or a high yield. However, if a manual open system suffices, plastic adherence is a reasonable alternative.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14578101     DOI: 10.1080/14653240310003053

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  19 in total

1.  Evaluation of gene expression profiles of immature dendritic cells prepared from peripheral blood mononuclear cells.

Authors:  Jeong Won Shin; Ping Jin; Yong Fan; Stefanie Slezak; Virginia David-Ocampo; Hanh M Khuu; Elizabeth J Read; Ena Wang; Francesco M Marincola; David F Stroncek
Journal:  Transfusion       Date:  2008-02-12       Impact factor: 3.157

Review 2.  Recent Advances in Good Manufacturing Practice-Grade Generation of Dendritic Cells.

Authors:  Sarah Cunningham; Holger Hackstein
Journal:  Transfus Med Hemother       Date:  2020-10-28       Impact factor: 3.747

3.  Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes.

Authors:  Wen Jing Sim; Frano Malinarich; Anna-Marie Fairhurst; John Edward Connolly
Journal:  J Vis Exp       Date:  2016-06-22       Impact factor: 1.355

4.  Monocyte isolation techniques significantly impact the phenotype of both isolated monocytes and derived macrophages in vitro.

Authors:  Marlene C Nielsen; Morten N Andersen; Holger J Møller
Journal:  Immunology       Date:  2019-11-27       Impact factor: 7.397

Review 5.  Generation of immunogenic and tolerogenic clinical-grade dendritic cells.

Authors:  Tahereh Kalantari; Eskandar Kamali-Sarvestani; Bogoljub Ciric; Mohamad H Karimi; Mohsen Kalantari; Alireza Faridar; Hui Xu; Abdolmohamad Rostami
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

6.  Identification of a sub-population of B cells that proliferates after infection with Epstein-Barr virus.

Authors:  Cynthia Megyola; Jianjiang Ye; Sumita Bhaduri-McIntosh
Journal:  Virol J       Date:  2011-02-25       Impact factor: 4.099

7.  Evaluation of 3 clinical dendritic cell maturation protocols containing lipopolysaccharide and interferon-gamma.

Authors:  Tae Hee Han; Ping Jin; Jiaqiang Ren; Stefanie Slezak; Francesco M Marincola; David F Stroncek
Journal:  J Immunother       Date:  2009-05       Impact factor: 4.456

8.  Controlled-rate freezer cryopreservation of highly concentrated peripheral blood mononuclear cells results in higher cell yields and superior autologous T-cell stimulation for dendritic cell-based immunotherapy.

Authors:  Timo Buhl; Tobias J Legler; Albert Rosenberger; Anke Schardt; Michael P Schön; Holger A Haenssle
Journal:  Cancer Immunol Immunother       Date:  2012-04-22       Impact factor: 6.968

9.  Molecular signatures of maturing dendritic cells: implications for testing the quality of dendritic cell therapies.

Authors:  Ping Jin; Tae Hee Han; Jiaqiang Ren; Stefanie Saunders; Ena Wang; Francesco M Marincola; David F Stroncek
Journal:  J Transl Med       Date:  2010-01-15       Impact factor: 5.531

10.  Toll-like receptor 4 engagement drives differentiation of human and murine dendritic cells from a pro- into an anti-inflammatory mode.

Authors:  Romana Luger; Sneha Valookaran; Natalie Knapp; Caterina Vizzardelli; Alexander M Dohnal; Thomas Felzmann
Journal:  PLoS One       Date:  2013-02-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.